|About||Users 6||Reviews||Exhibitors||Photos||Speakers||Travel Deals|
"Discovery, Translation, Commercialization: Developing CAR-T into viable, accessible therapies"
CAR-T Congress EU aims to address the opportunities and challenges that presently face the CAR-T field, to maximize the potential of this ground-breaking therapy. The key sessions include solid tumor targeting, overcoming the tumor microenvironment, multi-specific & dual targeting CARs, process development, scalability & automation, allogeneic vs autologous, the potential of off-the-shelf therapies, patient access, implementation & regulatory challenges, and much more.
Timings09:00 AM-06:00 PM (expected)
Entry FeesCheck Official Website
10 - 50 Exhibitors Estimated Count
Category & TypeConference
Medical & Pharma
Science & Research
Editions29 - 30 Jan 2020 Interested
30 - 31 Jan 2019
Official LinksWebsite Contacts
Claim this event
OrganizerSend Stall Book Request